Factsheets on the status of national PMTCT responses in the most affected countries.

Each of these 22 country-specific factsheets sets out strategic information on the state of PMTCT service-delivery and policy development, while also highlighting bottlenecks that must be tackled to reach national targets.

Cote d’Ivoire

Country Situation

HIV prevalence among adults (ages 15-49) in Cote d’Ivoire has declined slightly between 2001 and 2009, from 6.5% to 3.4%[1]. HIV prevalence among pregnant women (all ages) is slightly lower (3.0%) than the general adult population. In 2011, an estimated 16,100 pregnant women living with HIV delivered children and there were an estimated 4,400 new paediatric HIV infections[3].

Overall, the uptake of antenatal care and availability of PMTCT services in Cote d’Ivoire is moderate. In 2010, approximately 60% of pregnant women attended at least one ANC visit according to facility data[8] and PMTCT services were available in 52% of ANC facilities[9]. HIV testing among pregnant women increased from 6% in 2005 to 59% in 2010[10]. Although 68% of pregnant women living with HIV received more efficacious ARV regimens for PMTCT in 2011[3], only 44% of HIV-exposed infants received ARVs for PMTCT in 2010[10].

Cote d’Ivoire has adopted the WHO Option B regimen for prophylaxis and a costed national PMTCT scale-up plan (2012-2016) is in place[11].

Link to the Cote d’Ivoire Ministry of Health.